PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53

Biomarkers and mechanisms of poly (ADP-ribose) polymerase (PARP) inhibitor-mediated cytotoxicity in tumor cells lacking a BRCA-mutant or BRCA-like phenotype are poorly defined. We sought to explore the utility of PARP-1 inhibitor (PARPi) treatment with/without ionizing radiation in muscle-invasive b...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qi, Gheorghiu, Liliana, Drumm, Michael, Clayman, Rebecca, Eidelman, Alec, Wszolek, Matthew F., Olumi, Aria, Feldman, Adam, Wang, Meng, Marcar, Lynnette, Citrin, Deborah E., Wu, Chin-Lee, Benes, Cyril H., Efstathiou, Jason A., Willers, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970015/
https://www.ncbi.nlm.nih.gov/pubmed/29511347
http://dx.doi.org/10.1038/s41388-018-0130-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970015/
https://www.ncbi.nlm.nih.gov/pubmed/29511347
http://dx.doi.org/10.1038/s41388-018-0130-6

Ejemplares similares